Skip to content

Vision, Mission & Strategy

Vision

Our vision is to develop and commercialize new innovative drugs that offer both clinical relevance and patient benefit.

Mission

AcuCort identifies, develops and commercializes smart drugs based on existing and well-documented substances in indication areas where there is a great medical need and commercial interest in new and innovative drugs that bring benefits, such as simple administration.

Strategy

AcuCort’s overall strategy is to attract partners with regional or global market presence, as well as expertise and resources, in order to quickly launch the company’s innovative, user-friendly drugs with strong patent protection after regulatory approval.

The prerequisites for achieving the financial and operational goals as well as optimizing AcuCort’s business model are the company’s ability to develop innovative drugs with strong patent protection and then quickly commercialize them in prioritized markets globally through licensees and/or distributors.

  • We want to strengthen and develop long-term relationships with investors and potential shareholders in order to increase trust in the company and support the long-term goals.
  • We prioritize an active and continuous business development in order to manage sustainable funding and cash flow over time.
  • We focus on innovative drugs based on existing and well-documented substances in indication areas where there is a great medical need and commercial interest in new and innovative drugs that bring benefits, such as simple administration.
  • We want to attract partners with a regional or global market presence, as well as with expertise and resources, in order to quickly and successfully launch the company’s first approved drug Zeqmelit after regulatory approval.
  • We establish and care for a strong leadership and a competent operational team in combination with a complementary network of specialists, opinion leaders, partners, and suppliers.
  • We establish and maintain a highly experienced leadership and competent operational team combined with a network of specialists, key opinion leaders, partners, and suppliers.